BIG
NVAX icon

Brooklyn Investment Group’s Novavax NVAX Stock Holding History

Brooklyn Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-202
Closed -$1.27K – 2007
2025
Q2 		$1.27K Sell
202
-399
-66% -$2.64K ﹤0.01% 2878
2025
Q1 		$3.85K Buy
+601
New +$4.97K ﹤0.01% 1914

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brooklyn Investment Group's NVAX Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Novavax (NVAX) in Q3 2025, closing a stake of 202 shares — an estimated $1.27K sold.

Brooklyn Investment Group first reported a position in NVAX in Q1 2025 and held it in 2 quarters. The position peaked at $3.85K in Q1 2025. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 202 Novavax shares in Q3 2025, an estimated $1.27K.
  • Brooklyn Investment Group first reported a position in Novavax in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Novavax position peaked at $3.85K in Q1 2025.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.